60 Degrees Pharmaceuticals SXTP Cash Flow Statement (2022-2026)

NASDAQ SXTP
$1.13 +0.00 (+0.44%)
As of: Aug 21, 2026 · 11:35 AM EDT
Cash Flow Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -2.15M-1.45M-0.37M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-0.38M-1.88M-1.73M-2.32M-0.98M-2.09M
Depreciation and Depletion (Quarter) 0.01M0.01M0.01M0.01M0.01M0.01M0.00M407.000.00M0.00M0.01M0.01M0.01M0.01M0.02M0.02M
Share-based Compensation (Quarter) 5.38M-5.10M0.27M0.32M0.01M2.75M0.02M-0.02M0.14M-0.12M0.08M
Gains from Investment Securities (Quarter) 0.00M-0.34M-0.01M-6.11M
Asset Writedowns and Impairment (Quarter) 0.43M0.00M0.05M-0.19M-0.02M-0.25M
Cash from Operations (Quarter) -0.31M-0.07M-0.41M-0.31M-3.75M-0.06M-1.14M-1.19M-1.68M-1.64M-1.60M-1.45M-2.11M-1.69M-2.74M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.49M-0.82M0.01M765.000.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Amortization of Deferred Charges (Quarter) 0.03M0.02M0.01M
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.01M0.01M0.01M0.01M0.00M407.000.00M0.00M0.01M0.01M0.01M0.01M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter) 0.14M-0.15M0.04M0.04M0.01M0.09M0.08M-0.02M0.03M0.16M0.00M-0.19M0.38M-0.16M-0.17M
Change in Inventory (Quarter) -0.02M-0.05M0.11M-0.11M-0.06M-0.15M-0.03M-0.01M0.03M-0.01M0.33M0.03M-0.03M0.14M0.00M
Change in Accured Expenses (Quarter) 0.22M-0.03M0.08M0.22M-0.40M0.02M0.10M0.05M0.33M0.26M-0.25M0.45M0.04M0.01M
Other Working Capital Changes (Quarter) 0.06M0.03M-0.02M0.05M1.48M-0.99M-0.06M-0.09M0.25M-0.06M-0.13M-0.13M0.25M0.03M0.74M
Investing Activities
Capital Expenditures (Quarter) -0.00M0.03M0.00M0.01M-0.01M0.06M726.000.09M0.01M0.00M0.05M0.01M0.08M0.03M
Change in Acquisitions & Divestments (Quarter) 1.71M1.24M
Cash from Investing Activities (Quarter) 0.00M-0.06M-0.00M-0.02M-0.03M-0.07M-0.01M-0.13M-1.75M-0.00M1.70M-0.05M-0.03M-1.37M1.19M
Financing Activities
Other financing activities (Quarter) -0.15M0.00M1.91M0.00M
Cash from Financing Activities (Quarter) -0.07M0.18M0.32M5.97M1.90M-865.005.15M973.001.70M4.28M0.46M3.37M
Additional items
Exchange Rate Effect (Quarter) -0.00M-374.000.01M0.05M-824.000.00M0.00M-0.00M-0.01M0.02M0.00M-0.00M0.01M
Change in Cash (Quarter) -0.31M-0.17M-0.23M-0.01M2.20M-0.08M0.75M-1.32M1.72M-1.64M1.79M-1.48M2.15M-2.61M1.83M
Free Cash Flow (Quarter) -0.31M-0.10M-0.42M-0.33M-3.74M-0.12M-1.14M-1.28M-1.69M-1.64M-1.60M-1.50M-2.12M-1.77M-2.77M
Net Cash Flow (Quarter) -0.31M-0.19M-0.23M-0.01M2.19M-0.13M0.75M-1.32M1.72M-1.64M1.80M-1.50M2.15M-2.60M1.82M